Roles of Randomized Controlled Trials in Establishing Evidence-Based Gender-Affirming Care and Advancing Health Equity
This article reviews the design of a recently published randomized controlled trial (RCT) on immediate vs delayed access to gender-affirming hormones for transgender and gender-diverse (TGD) people and outlines key learning points that clinicians should know about how RCTs can and cannot contribute to advancing health equity for TGD people.
Authors
- Theodore E. Schall (ORCID: https://orcid.org/0000-0002-0353-2657)
- Jacob Moses (ORCID: https://orcid.org/0000-0001-8089-3870)
- Kaitlyn Jaffe (ORCID: https://orcid.org/0000-0002-5084-4100)
Institutions
- Department of Health (TW)
- Department of Health (IE)
- The University of Texas Medical Branch at Galveston (US)
Publication Details
- Journal
- The AMA Journal of Ethic
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1001/amajethics.2024.684
- Citations
- 10
- Primary Topic
- Sex and Gender in Healthcare
- Type
- article
- Field-Weighted Citation Impact
- 5.43